Skip Navigation

European Heart Journal 2004 25(6):514-522; doi:10.1016/j.ehj.2003.09.006
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ortlepp, J. R
Right arrow Articles by Hoffmann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortlepp, J. R
Right arrow Articles by Hoffmann, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis

Jan R Ortleppa,*, Fabian Schmitza, Vera Mevissena, Stefan Weißb, Jürgen Husterb, Richard Dronskowskib, Georg Langebartelsc, Rüdiger Autschbachc, Klaus Zerresd, Christian Webere, Peter Hanratha and Rainer Hoffmanna

a Medical Clinic I, University Hospital of Aachen, Aachen University of Technology, Pauwelsstrasse 30, 52152 Aachen, Germany
b Institute of Inorganic Chemistry, Aachen University of Technology, Aachen, Germany
c Clinic for Cardiac Surgery, University Hospital of Aachen, Aachen University of Technology, Aachen, Germany
d Institute for Human Genetics, University Hospital of Aachen, Aachen University of Technology, Aachen, Germany
e Division of Molecular Cardiovascular Research, Medical Clinic I, Aachen University of Technology, Pauwelsstrasse 30, 52057 Aachen, Germany

Received March 25, 2003; revised August 9, 2003; accepted September 4, 2003 * Corresponding author. Tel.: +49-241-8089300/8088660; fax: +49-241-8082414
E-mail address: jrortlepp{at}ukaachen.de

Aims The study evaluated the relationship between cardiovascular risk factors (CRF), gene polymorphism, calcification and fibrosis of stenotic aortic valves.

Methods and results The calcium content of 187 excised stenotic aortic valves was determined using atomic absorption spectroscopy. Hydroxyproline content was quantified. Left-heart catheterization was performed. CRF and genotypes of the interleukin 10, connective tissue growth factor (CTGF) and chemokine receptor 5 (CCR5) polymorphisms were assessed. Calcification consisted of Ca-deficient hexagonal hydroxyapatite, Ca10–x(HPO4)x(PO4)6–x(OH)2–x; with . Calcification (quintiles) was positively associated with the mean gradient across the aortic valve (44±14, 52±17, 54±16, 60±15, 68±19 mmHg; ). Males () had a higher degree of calcification (26.1±8.9 vs 20.8±9.2 mass%; ), despite the same mean gradient across the aortic valve (56±17 vs 56±19 mmHg; ). CRF were not, whereas interleukin 10 polymorphisms –1082, –819, and –592 were significantly associated with the degree of calcification. Furthermore, if certain allele carriers had additionally the rare CCR5 or CTGF allele the degree of calcification was higher.

Conclusion Calcification of stenotic aortic valves consists of Ca-deficient hexagonal hydroxyapatite. Gender and genetic polymorphisms have an impact on the degree of aortic valve calcification.

Key Words: Calcification • Degenerative calcific aortic stenosis • Gene polymorphisms • Cardiovascular risk factors • Mass spectroscopy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 493 - 504.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Bosse, P. Mathieu, and P. Pibarot
Genomics: The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. Novaro, R. Katz, R. J. Aviles, J. S. Gottdiener, M. Cushman, B. M. Psaty, C. M. Otto, and B. P. Griffin
Clinical Factors, But Not C-Reactive Protein, Predict Progression of Calcific Aortic-Valve Disease: The Cardiovascular Health Study
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1992 - 1998.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J R Ortlepp, M Pillich, V Mevissen, C Krantz, M Kimmel, R Autschbach, G Langebartels, J Erdmann, R Hoffmann, and K Zerres
APOE alleles are not associated with calcific aortic stenosis
Heart, October 1, 2006; 92(10): 1463 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Liebe, M. Brueckmann, M. Borggrefe, and J. J. Kaden
Statin therapy of calcific aortic stenosis: hype or hope?
Eur. Heart J., April 1, 2006; 27(7): 773 - 778.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. V. Freeman and C. M. Otto
Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies
Circulation, June 21, 2005; 111(24): 3316 - 3326.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.